Early-stage ovarian cancer: Clinical outcome and analysis of prognostic factors-Results from a prospective registry of GEICO (Spanish Group for Ovarian Cancer Research).

被引:0
|
作者
Ojeda, Belen
Maria Churruca, Cristina
Romero, Ignacio
Redondo, Andres
Calvo, Elisa
Santaballa, Ana
del Campo, Josep M.
Sebio, Ana
Lainez, Nuria
Bover, Isabel
Romeo, Margarita
Caballero, Cristina
Garcia-Martinez, Elena
Martinez, Jeronimo
Herrero, Ana
Beatriz Sanchez, Ana
De Juan, Ana
Hernando Polo, Susana
Ruiz, Nuria
Poveda, Andres
机构
[1] GEICO, Barcelona, Spain
[2] Hosp Santa Creu & Sant Pau, Dept Med Oncol, Barcelona, Spain
[3] Hosp Donostia, San Sebastian, Spain
[4] Inst Valenciano Oncol, Area Clin Oncol Ginecol, Valencia, Spain
[5] Hosp Univ La Paz, Madrid, Spain
[6] Hosp Univ Virgen del Rocio, Seville, Spain
[7] Hosp Univ & Politecn La Fe, Valencia, Spain
[8] Vail dHebron Hosp, Barcelona, Spain
[9] Complejo Hosp Navarra, Pamplona, Spain
[10] GEICO, Mallorca, Spain
[11] Son Llatzer Univ Hosp, Mallorca, Spain
[12] Hostal Germans Trias & Pujol, Inst Catala Oncol, Med Oncol Serv, Badalona, Spain
[13] Hosp Gen Univ Valencia, Valencia, Spain
[14] Hosp Gen Univ Morales Meseguer, Med Oncol, Murcia, Spain
[15] Hosp Univ Virgen de la Arrixaca, Murcia, Spain
[16] Hosp Miguel Servet, Zaragoza, Spain
[17] Hosp Gen Univ Elche, Elche, Spain
[18] Hosp Marques de Valdecilla, Santander, Spain
[19] Hosp Univ Fdn Alcorcon, Alcorcon, Spain
[20] Hosp Prov Castellon, Castellon de La Plana, Spain
关键词
D O I
10.1200/jco.2014.32.15_suppl.5582
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
5582
引用
收藏
页数:1
相关论文
共 50 条
  • [21] CLINICAL DIFFERENCES AMONG STAGE IC OVARIAN CARCINOMA: A GEICO PROSPECTIVE EARLY STAGE DATABASE ANALYSIS
    Romero, I.
    Lopez-Guerrero, J. A.
    Del Campo, J. M.
    Churruca, C.
    Lainez, N.
    Redondo, A.
    Calvo, E.
    Herrero, A.
    Bover, I.
    Santaballa, A.
    Garcia-Martinez, E.
    Caballero, C.
    Sanchez-Heras, B.
    Ojeda, B.
    Romeo, M.
    Mendiola, C.
    Casado, A.
    Martinez, J.
    Girones, R.
    Poveda, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2014, 24 (09) : 341 - 342
  • [22] Compliance to clinical guidelines for early-stage epithelial ovarian cancer in relation to patient outcome
    Sijmons, Edith A.
    van Lankveld, Marieke A. L.
    Witteveen, Petronella O.
    Peeters, Petra H. M.
    Koot, Veronica C. M.
    van Leeuwen, Jules Schagen
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2007, 131 (02) : 203 - 208
  • [23] Prognostic impact of tumor anemia in early-stage epithelial ovarian cancer
    Obermair, A
    Petru, E
    Windbichler, G
    Peters-Engl, C
    Graf, AH
    Stummvoll, W
    Kaider, A
    Kurschel, S
    Kölbl, H
    Sevelda, P
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S233 - S233
  • [24] Predictive factors of recurrence in patients with early-stage epithelial ovarian cancer
    Ditto, Antonino
    Maggiore, Umberto Leone Roberti
    Bogani, Giorgio
    Martinelli, Fabio
    Chiappa, Valentina
    Evangelista, Maria Teresa
    Liberale, Viola
    Ferrero, Simone
    Raspagliesi, Francesco
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 145 (01) : 28 - 33
  • [25] Multivariate analysis of prognostic factors in stage I ovarian cancer
    Kodama S.
    Kase H.
    Tanaka K.
    Tokunaga A.
    Sudo N.
    Takahashi T.
    Honma S.
    International Journal of Clinical Oncology, 1999, 4 (2) : 90 - 95
  • [26] The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer
    Bizzarri, Nicolo
    D'Indinosante, Marco
    Marchetti, Claudia
    Tudisco, Riccardo
    Turchiano, Francesca
    Scambia, Giovanni
    Fagotti, Anna
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2023, 28 (02) : 314 - 320
  • [27] The prognostic role of systemic inflammatory markers in apparent early-stage ovarian cancer
    Nicolò Bizzarri
    Marco D’Indinosante
    Claudia Marchetti
    Riccardo Tudisco
    Francesca Turchiano
    Giovanni Scambia
    Anna Fagotti
    International Journal of Clinical Oncology, 2023, 28 : 314 - 320
  • [28] The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)
    Pizarro, David
    Romero, Ignacio
    Perez-Mies, Belen
    Redondo, Andres
    Caniego-Casas, Tamara
    Carretero-Barrio, Irene
    Cristobal, Eva
    Gutierrez-Pecharroman, Ana
    Santaballa, Ana
    D'Angelo, Emanuela
    Hardisson, David
    Vieites, Begona
    Matias-Guiu, Xavier
    Estevez, Purificacion
    Guerra, Eva
    Prat, Jaime
    Poveda, Andres
    Lopez-Guerrero, Jose Antonio
    Palacios, Jose
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (13)
  • [29] Ovarian cancer patients with localized relapse: Clinical outcome and prognostic factors
    Petrillo, M.
    Fagotti, A.
    Ferrandina, G.
    Fanfani, F.
    Costantini, B.
    Vizzielli, G.
    Anchora, L. Pedone
    Nero, C.
    Margariti, P. A.
    Scambia, G.
    GYNECOLOGIC ONCOLOGY, 2013, 131 (01) : 36 - 41
  • [30] EFFICACY OF TRABECTEDIN IN METASTATIC UTERINE LEIOMYOSARCOMA: A RETROSPECTIVE MULTICENTER STUDY OF THE SPANISH OVARIAN CANCER RESEARCH GROUP (GEICO)
    Rubio, M. J.
    Lecumberri, M. J.
    Varela, S.
    Alarcon, J.
    Ortega, M. E.
    Gaba, L.
    Espinos, J.
    Calzas, J.
    Barretina, P.
    Ruiz, I.
    Santaballa, A.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2018, 28 : 1173 - 1173